Multiple Sclerosis Trial, Recruiting NCT06506929 Sponsor: Hunter College of City University of New York Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06506929
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been officially diagnosed with Multiple Sclerosis (MS)
  • Your level of disability from MS falls within a specific range on a standard disability scale (EDSS score between 7.0 and 8.0, which generally means needing significant assistance with movement — confirm with trial site)
  • You are able to read, understand, and sign a consent form on your own

Who may not be able to join:

  • You have had an MS flare-up or worsening of symptoms in the 4 weeks before the study would begin
  • You have bone, joint, heart, lung, or other nerve-related problems (not caused by MS) that would make it difficult for you to take part in the study activities

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Herbert Karpatkin, Hunter College of City University of New York

Phone: 212-396-7115

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hunter College of City University of New York
Registry
ClinicalTrials.gov
Start date
10 July 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Multiple Sclerosis Physical Frailty Functional Assessment (MSPFFA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov